Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezosentan effect on blood pressure in PAH
NCT01094067Phase 2Terminated
- Sponsor
- Idorsia
- Start
- Sep 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of tezosentan in pulmonary arterial hypertension (PAH), sponsored by Idorsia. Started Sep 2010; status: terminated.
02
Drugs
tezosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01094067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01094067.